{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:29:32Z","timestamp":1787758172396,"version":"build-2784847793"},"reference-count":18,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,8]]},"abstract":"\n Purpose:<\/jats:title>\n To determine the efficacy of subliminal cyclophotocoagulation in reducing intraocular pressure (IOP) and to assess the safety profile of the procedure.<\/jats:p>\n <\/jats:sec>\n \n Methods:<\/jats:title>\n \n We reviewed the charts of all patients who underwent subliminal cyclophotocoagulation between August 2019 and August 2020. The IOP, number of antiglaucoma medications, and visual acuity were compared at baseline and at 6 months. The post-laser complications were noted. Paired\n t<\/jats:italic>\n -test, Wilcoxon rank-sum test, and McNemar test were used for analysis.\n <\/jats:p>\n <\/jats:sec>\n \n Results:<\/jats:title>\n \n This study included 40 eyes of 40 patients. The most frequent diagnosis was neovascular glaucoma (55%), followed by primary open-angle glaucoma (17.5%). The mean IOP reduced from 32 to 21 mmHg (mean IOP reduction: 32%, 95% confidence interval [CI]: 27%\u201337%,\n P<\/jats:italic>\n < 0.001). Mean number of antiglaucoma medications declined from 3.2 to 1.9 (\n P<\/jats:italic>\n < 0.001). Use of oral acetazolamide decreased from 62% to 5% (\n P<\/jats:italic>\n < 0.001). The success rate of the procedure at 6 months was 55%. One patient had unexplained visual acuity decline after the procedure.\n <\/jats:p>\n <\/jats:sec>\n \n Conclusion:<\/jats:title>\n Subliminal sub-cyclophotocoagulation is effective in treating refractory glaucoma in the Indian population. It decreases the medication burden. However, subliminal lasers can also cause vision-threatening complications such as hypotony, uveitis, and optic nerve hypoperfusion. So, clinicians should be cautious when using sub-cyclophotocoagulation in patients with good vision.<\/jats:p>\n <\/jats:sec>","DOI":"10.4103\/ijo.ijo_288_22","type":"journal-article","created":{"date-parts":[[2022,8,4]],"date-time":"2022-08-04T11:45:11Z","timestamp":1659613511000},"page":"2911-2914","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Efficacy and safety of subliminal transscleral cyclophotocoagulation in uncontrolled glaucoma"],"prefix":"10.4103","volume":"70","author":[{"given":"Ferzana","family":"Mohammed","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, Govt Medical College, Kozhikode, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Somasundaran","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Govt Medical College, Kozhikode, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suma","family":"Unnikrishnan","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Govt Medical College, Kozhikode, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P T","family":"Jyothi","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, Govt Medical College, Kozhikode, Kerala, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,7,29]]},"reference":[{"key":"B1-20240828","doi-asserted-by":"crossref","first-page":"55","DOI":"10.4103\/jovr.jovr_190_17","article-title":"Evolution of cyclophotocoagulation","volume":"13","author":"Ndulue","year":"2018","journal-title":"J Ophthalmic Vis Res"},{"key":"B2-20240828","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1097\/IJG.0000000000001552","article-title":"Micropulse trans-scleral cyclophotocoagulation in patients with glaucoma:1- and 2-year treatment outcomes","volume":"29","author":"de Crom","year":"2020","journal-title":"J Glaucoma"},{"key":"B3-20240828","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.ogla.2019.02.002","article-title":"Micropulse transscleral cyclophotocoagulation:A look at long-term effectiveness and outcomes","volume":"2","author":"Sarrafpour","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"B4-20240828","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ogla.2019.08.009","article-title":"Micropulse transscleral diode laser cyclophotocoagulation in refractory glaucoma:Short-term efficacy, safety, and impact of surgical history on outcomes","volume":"2","author":"Garcia","year":"2019","journal-title":"Ophthalmol Glaucoma"},{"key":"B5-20240828","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/IJG.0000000000000934","article-title":"Clinical efficacy and safety profile of micropulse transscleral cyclophotocoagulation in refractory glaucoma","volume":"27","author":"Williams","year":"2018","journal-title":"J Glaucoma"},{"key":"B6-20240828","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/IJG.0000000000001644","article-title":"Micropulse cyclophotocoagulation:A multicenter study of efficacy, safety, and factors associated with increased risk of complications","volume":"29","author":"Radhakrishnan","year":"2020","journal-title":"J Glaucoma"},{"key":"B7-20240828","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s10792-021-01697-1","article-title":"Micropulse trans-scleral diode laser cyclophotocoagulation in refractory glaucoma:An initial experience in Indian eyes","volume":"41","author":"Ariga","year":"2021","journal-title":"Int Ophthalmol"},{"key":"B8-20240828","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/tjosr.tjosr_21_20","article-title":"Early results of SubCyclo laser in glaucoma patients visiting a tertiary care hospital in South India:A pilot study","volume":"58","author":"Abbagani","year":"2020","journal-title":"TNOA J Ophthalmic Sci Res"},{"key":"B9-20240828","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/IJG.0000000000001409","article-title":"Comparative effectiveness and tolerance of subliminal subthreshold transscleral cyclophotocoagulation with a duty factor of 25% versus 31.3% for advanced glaucoma","volume":"29","author":"Keilani","year":"2020","journal-title":"J Glaucoma"},{"key":"B10-20240828","doi-asserted-by":"crossref","first-page":"296","DOI":"10.22336\/rjo.2018.45","article-title":"Subcyclo laser procedure results in patients with glaucoma","volume":"62","author":"Lutic","year":"2018","journal-title":"Rom J Ophthalmol"},{"key":"B11-20240828","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1177\/1120672119877586","article-title":"Micropulse transscleral cyclophotocoagulation using a standard protocol in patients with refractory glaucoma naive of cyclodestruction","volume":"31","author":"Souissi","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"B12-20240828","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1177\/1120672120914231","article-title":"Outcomes of micropulse transscleral cyclophotocoagulation in primary open-angle glaucoma, pseudoexfoliation glaucoma, and secondary glaucoma","volume":"31","author":"Tekeli","year":"2021","journal-title":"Eur J Ophthalmol"},{"key":"B13-20240828","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1097\/IJG.0000000000001339","article-title":"Outcomes of micropulse transscleral cyclophotocoagulation in eyes with good central vision","volume":"28","author":"Varikuti","year":"2019","journal-title":"J Glaucoma"},{"key":"B14-20240828","doi-asserted-by":"crossref","first-page":"2","DOI":"10.4172\/2155-9570.1000620","article-title":"Clinical outcomes of micropulsed transcleral cyclophotocoagulation in moderate to severe glaucoma","volume":"7","author":"Toyos","year":"2016","journal-title":"J Clin Exp Ophthalmol"},{"key":"B15-20240828","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1097\/IJG.0000000000000715","article-title":"Micropulse cyclophotocoagulation:Initial results in refractory glaucoma","volume":"26","author":"Emanuel","year":"2017","journal-title":"J Glaucoma"},{"key":"B16-20240828","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/j.1442-9071.2010.02238.x","article-title":"Micropulse transscleral diode laser cyclophotocoagulation in the treatment of refractory glaucoma","volume":"38","author":"Tan","year":"2010","journal-title":"Clin Exp Ophthalmol"},{"key":"B17-20240828","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/ceo.12360","article-title":"Micropulse versus continuous wave transscleral diode cyclophotocoagulation in refractory glaucoma:A randomized exploratory study","volume":"43","author":"Aquino","year":"2015","journal-title":"Clin Exp Ophthalmol"},{"key":"B18-20240828","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/sj.eye.6702345","article-title":"Long-term efficacy and visual acuity following transscleral diode laser photocoagulation in cases of refractory and non-refractory glaucoma","volume":"21","author":"Ansari","year":"2007","journal-title":"Eye"}],"container-title":["Indian Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_288_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T15:08:33Z","timestamp":1787756913000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/ijo.IJO_288_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,29]]},"references-count":18,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.4103\/ijo.ijo_288_22","relation":{},"ISSN":["0301-4738","1998-3689"],"issn-type":[{"value":"0301-4738","type":"print"},{"value":"1998-3689","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,29]]},"assertion":[{"value":"2022-01-28","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-05","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}